Clinical Trials
All Clinical Trials - Page 37 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02115282Phase 3Active Not Recruiting
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Gonadorelin
- NCT02079870Phase 1Completed
Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
Semaglutide
- NCT04184947N/ACompleted
Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
Liraglutide
- NCT02475499N/ACompleted
Incretin-based Drugs and Pancreatic Cancer
Liraglutide
- NCT02187250Phase 4Completed
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
Liraglutide
- NCT01919489Phase 4Completed
Liraglutide Hospital Discharge Trial
Liraglutide
- NCT02456428N/ACompleted
Incretin-based Drugs and the Risk of Heart Failure
Liraglutide
- NCT02014740Phase 4Completed
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
Liraglutide
- NCT02073929Phase 4Completed
LIPT - Liraglutide in Polycystic Ovary Syndrome
Liraglutide
- NCT02654665Phase 3Unknown
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
Liraglutide
- NCT02476760N/ACompleted
Incretin-based Drugs and Acute Pancreatitis
Liraglutide
- NCT02070510Phase 1Completed
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects
Semaglutide
- NCT02003209Phase 3Completed
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Gonadorelin
- NCT02077946N/ACompleted
A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
Liraglutide
- NCT02674893Phase 4Terminated
Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
Liraglutide
- NCT02005887Phase 2Completed
TRial on the Endocrine Activity of Neoadjuvant Degarelix
Gonadorelin
- NCT01973842Phase 2Unknown
Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients
Gonadorelin
- NCT02890082Phase 2Active Not Recruiting
Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer
Gonadorelin
- NCT02072096Phase 4Terminated
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Liraglutide
- NCT02041234Phase 4Completed
Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
Liraglutide
- NCT01879917Phase 2/Phase 3Completed
Liraglutide in Newly Onset Type 1 Diabetes.
Liraglutide
- NCT01938235Phase 2Unknown
Exenatide for Myocardial Protection During Reperfusion Study
Exenatide
- NCT02084251Phase 1Completed
Clinical Trial for PB-119 in Healthy Subjects (Phase I)
Exenatide
- NCT02081118Phase 2Completed
Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Exenatide
- NCT02129985Phase 4Unknown
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
Exenatide
- NCT02560376EARLY_Phase 1Unknown
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Exenatide
- NCT01917656Phase 4Completed
Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
Liraglutide
- NCT02127541N/ACompleted
New Imaging Procedure for the Localisation of Insulinoma
Exenatide
- NCT04027712N/AUnknown
Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD
MOTS-c
- NCT03745027N/ACompleted
Follicular Fluid Sialic Acid Levels in IVF Cycles
Gonadorelin
- NCT01632592N/AWithdrawn
Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue
Tesamorelin
- NCT02507245N/ACompleted
Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
Sermorelin
- NCT02877992N/ACompleted
Tachykinin and Kisspeptin Expression in Human Granulosa and Cumulus Cells
Kisspeptin
- NCT02344550Phase 2Completed
Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer
Gonadorelin
- NCT02016846Phase 3Unknown
Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes
Liraglutide
- NCT02483299Phase 4Completed
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
Liraglutide
- NCT01843075Phase 2Unknown
Evaluating Liraglutide in Alzheimer's Disease
Liraglutide
- NCT02057172Phase 2Completed
Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Liraglutide
- NCT02036372N/ACompleted
Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
Liraglutide
- NCT02315001Phase 2Completed
Liraglutide to Improve corONary Haemodynamics During Exercise streSS
Liraglutide
- NCT02022254Phase 1Completed
Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
Semaglutide
- NCT02043054Phase 3Completed
Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Liraglutide
- NCT02016911Phase 1Completed
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
Semaglutide
- NCT02014259Phase 1Completed
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
Semaglutide
- NCT01930188Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
Semaglutide
- NCT01885208Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
Semaglutide
- NCT01907854Phase 4Completed
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Liraglutide
- NCT02008682Phase 4Completed
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
Liraglutide
- NCT02059564Phase 1Unknown
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Liraglutide
- NCT02020616Phase 1/Phase 2Terminated
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Exenatide